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The human immune cell response against bacterial biofilms is a crucial, but still poorly
investigated area of research. Herein, we aim to establish an in vitro host cell-biofilm
interaction model suitable to investigate the peripheral blood mononuclear cell (PBMC)
response to Pseudomonas aeruginosa biofilms. P. aeruginosa biofilms were obtained by
incubating bacteria in complete RPMI 1640 medium with 10% human plasma for 24 h.
PBMC obtained from healthy donors were added to preformed P. aeruginosa biofilms.
Following a further 24 h incubation, we assessed (i) PBMC viability and activation; (ii)
cytokine profiles in the supernatants; and (iii) CFU counts of biofilm forming bacteria.
Cell-death was <10% upon 24 h incubation of PBMC with P. aeruginosa biofilms.
PBMC incubated for 24 h with preformed P. aeruginosa biofilms were significantly more
activated compared to PBMC incubated alone. Interestingly, a marked activation of
CD56+CD3− natural killer (NK) cells was observed that reached 60% of NK cells as
an average of different donors. In the culture supernatants of PBMC co-cultured with
P. aeruginosa biofilms, not only pro-inflammatory (IL-1β, IFN-γ, IL-6, and TNF-α) but
also anti-inflammatory (IL-10) cytokines were significantly increased as compared to
PBMC incubated alone. Furthermore, incubation of biofilms with PBMC, caused a
statistically significant increase in the CFU number of P. aeruginosa, as compared to
biofilms incubated without PBMC. In order to assess whether PBMC products could
stimulate the growth of P. aeruginosa biofilms, we incubated preformed P. aeruginosa
biofilms with or without supernatants obtained from the co-cultures of PBMC with
biofilms. In the presence of the supernatants, the CFU count of biofilm-derived P.
aeruginosa, was two to seven times higher than those of biofilms incubated without
supernatants (P < 0.01). Overall, the results obtained shed light on the reciprocal
interaction between human PBMC and P. aeruginosa biofilms. P. aeruginosa biofilms
induced PBMC activation and cytokine secretion but, in turn, the presence of PBMC
and/or PBMC-derived components enhanced the number of P. aeruginosa biofilm
associated bacteria. This may indicate a successful bacterial defensive/persistence
strategy against immune response.
Keywords: peripheral blood mononuclear cells, cytokines, biofilm, Pseudomonas aeruginosa, human immune
response to biofilm, natural killer cells
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INTRODUCTION
Pseudomonas aeruginosa is an environmental Gram-negative
opportunistic pathogen involved in a large spectrum of
infections, especially in immunocompromised and hospitalized
patients (Driscoll et al., 2007). Infections caused by P. aeruginosa
include acute and chronic respiratory infections, hospital-
acquired urinary tract infections, chronic infections of wounds,
otitis, endocarditis, osteomyelitis, corneal infections, and
systemic infections (Driscoll et al., 2007). P. aeruginosa plays a
particularly critical role in cystic fibrosis (CF) patients, largely
contributing to the rapid decline in pulmonary function and
representing an important cause of morbidity and mortality
(Malhotra et al., 2019). The bacterium is also frequently involved
in infections associated to the use of intravascular catheters
(Raad, 1998), urinary catheters (Vipin et al., 2019), prosthetic
implants (Martinez-Pastor et al., 2009) and other medical
devices that represent essential tools of the modern medicine
(Tolker-Nielsen, 2014). The pathogenesis of many P. aeruginosa
infections depends on a striking ability of the bacterium to form
biofilms, complex bacterial communities adhering on a substrate,
such as mucosal surfaces or invasive medical devices (Tolker-
Nielsen, 2014). In biofilms, bacterial cells are typically embedded
within a self-produced extracellular polymeric substance
(EPS), primarily composed of polysaccharides, proteins, and
extracellular DNA (eDNA) (Flemming and Wingender, 2010).
EPS plays a crucial role in maintaining the biofilm architecture
ensuring a highly hydrated microenvironment and favoring
the interactions among bacterial cells. The biofilm mode of
growth provides the bacteria with enormous advantages to
establish an infection as renders them extremely recalcitrant to
both antimicrobial treatment and immune responses (Batoni
et al., 2016). In fact, the EPS acts like a barrier that hampers
the diffusion of antibiotics as well as host immune cells. In this
regard, it has been reported that antibodies or phagocytic cells at
most enter the water channels intercalating the micro-colonies
that constitute a mature biofilm (Costerton et al., 2003), but
hardly penetrate into the deep layers of the micro-communities,
especially when biofilms are grown under static conditions (Leid
et al., 2002).
Despite the recognized clinical importance of biofilms,
the human immune response against infectious biofilms is a
research area that necessitates to be thoroughly investigated as
the majority of immune research investigations have focused
on bacteria in the planktonic state (Moser et al., 2017). A
deep understanding of the complex interactions that establish
between biofilm bacteria and the immune system may help in
identifying new targets and strategies of immune intervention
against biofilm-associated infections. In addition, quantitative
measurements of the host responses to biofilms may serve as
diagnostic tools or possible biomarkers for tracing the course of
an infection (Moser et al., 2017; Campoccia et al., 2019).
The host response against P. aeruginosa biofilms is particularly
complex and it is believed to involve the integrated activity
of an array of cell types of both the innate and adaptive
immune systems (Maurice et al., 2018). The dynamic interplay
between P. aeruginosa and the host immune system is one of
the major determinants of bacterium’s pathogenicity and may
shape the phenotype of chronic lung infections, which range from
acute exacerbations to sub-clinical slowly progressing conditions
characterized by the adaptation of the bacterium to the host and
attenuated immune responses (Faure et al., 2018).
The in vitro human immune response to P. aeruginosa
biofilms is a research area still poorly investigated. The cytotoxic
effect exerted by the bacterium on a variety of host cell
types is one of the main hurdles that hampers the study of
the host immune response in vitro (Bishop et al., 1987; El-
Housseiny et al., 2013). In addition, most of the in vitro studies
conducted so far have investigated neutrophil or monocyte
response to P. aeruginosa biofilms (Jesaitis et al., 2003; Walker
et al., 2005; Ciornei et al., 2010), while little is known on the
human peripheral blood mononuclear cells (PBMC) and biofilm
interaction. In the present study, we sought to establish an in
vitro model of P. aeruginosa biofilms and human PBMC co-
culture suitable to assess immune responses (e.g., expression
of activation markers, cytokine production) of different PBMC
subsets. By finely tuning the experimental parameters, such
as PBMC and bacteria numbers, incubation times, type of
medium used for biofilm formation, we could obtain mature
biofilms of P. aeruginosa in eukaryotic cell-compatible medium
RPMI 1640 and maintain the P. aeruginosa-biofilm:PBMC co-
culture for at least 24 h, with minimal cell death. Interestingly,
the results obtained disclosed a reciprocal interaction between
human PBMC and P. aeruginosa biofilms. P. aeruginosa biofilms
induced PBMC activation and cytokine secretion but, in turn,
PBMC and/or PBMC components enhanced the number of P.
aeruginosa biofilm associated bacteria after 24 h of co-culture.
These results suggest a successful bacterial defensive/persistence
strategy in response to host immune response.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
The reference strain P. aeruginosa ATCC 27853 was used
in the present study. In addition, the reference strain PAO1
(ATCC 15692) and two P. aeruginosa clinical strains isolated
from abdominal fluid (PA-AF) and CF lung (PA-CF) at the
Microbiology Unit of the University Hospital of Pisa, Italy were
employed in some experiments. Stock cultures were prepared by
growing bacterial strains in Tryptone Soy Broth (TSB) (Oxoid,
Basingstoke, UK) at 37◦C until mid-logarithmic phase. Bacterial
suspensions were then aliquoted and stored at−80◦C in the same
medium until use.
Biofilm Formation
An aliquot of frozen P. aeruginosa culture was thawed, diluted
100 times in TSB, and incubated at 37◦C overnight (18 h)
with shaking (600 rpm). A volume of 500 µl from the
stationary phase culture was centrifuged at 4,000 × g for
5min. at room temperature (RT) and the pellet was re-
suspended in the same volume of complete medium consisting
of RPMI 1640 (Euroclone S.p.A, Pero, Milan) supplemented
with 10% heat-inactivated pooled human plasma and 2mM L-
glutamine (Euroclone). Preliminary experiments were performed
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to establish the optimal bacterial number ensuring biofilm
formation in such medium. Addition of a 100 µl bacterial
suspension containing ∼1 × 106 colony forming unit (CFU)
per well to 96-well flat bottom plates (Euroclone) was found to
be optimal for the experimental purposes. To this aim, initial
bacteria suspension were diluted in complete RPMI medium
to reach such bacterial density. To assess the exact number
of initial bacteria used in each experiment, an aliquot was
plated on Tryptone Soya Agar (TSA; Oxoid, Basingstoke, UK)
plates for CFU count. The 96-well plates were incubated at
37◦C for 24 h without shaking to allow biofilm formation.
Following the incubation, biofilms were gently washed three
times with phosphate buffered saline (PBS) to remove non-
adherent cells and incubated for further 24 h in the absence
or in the presence of PBMC (see below) in complete RPMI in
humidified air containing 5% CO2. Following 24 and 48 h of
incubation, biofilm-associated bacterial cells were mechanically
detached from the bottom of the wells by scratching 60 s with a
pipette tip, subjected to vigorous vortexing, serially diluted and
plated on TSA (Oxoid). After an incubation of 24 h at 37◦C the
number of biofilm-associated bacteria (CFU/ml) was evaluated
by CFU counting.
Analysis of P. aeruginosa Biofilms Grown in
Complete RPMI 1640 by Confocal Laser
Scanning Microscopy (CLSM)
P. aeruginosa biofilms grown in complete RPMI were analyzed
by CLSM as previously described (Maisetta et al., 2016; Di Luca
et al., 2018). Briefly, biofilms were formed for 24 and 48 h in the
same conditions as explained above (see “Biofilm formation”) but
using 8 well ibiTreat polymer coverslips (ibidi GmbH, Gräfelfing,
Germany). Following incubation, biofilms were gently washed
with sterile MilliQ water (Millipore), and stained with green
fluorescent Syto9 (live bacteria) and red fluorescent propidium
iodide (dead bacteria) (FilmtracerTM LIVE/DEADTM Biofilm
Viability Kit, Thermo Fisher Scientific). Stained samples were
observed under TCS SP5 II (Leica Microsystems Srl, Buccinasco,
Milan) confocal microscope (interfaced with a 488 nm Argon
laser), using a 60× 1.25 NA water immersion objective. For each
sample, the entire well surface and depth were scanned. 10µm
Axial stacks in the Z plane, with a slice thickness of 1µm, were
taken through representative areas of biofilm.
PBMC:Biofilm Co-culture
Peripheral blood (buffy coat) from healthy subjects was obtained
from the donors attending the Transfusion center of Pisa
University Hospital or from healthy volunteers. An informed
consent was obtained from each donor. The study was conducted
in accordance with the Declaration of Helsinki, and the protocol
was approved by the local Ethical Committee (Protocol 34743,
28/06/2018). PBMC were isolated by standard gradient protocol
as described previously (Esin et al., 1996). In brief, blood
was diluted with PBS (1:1 ratio) containing 10% sodium
citrate (v/v), layered on a density gradient (Lymphoprep,
Cedarlane, Canada), and centrifuged at 160 × g for 20min
at RT. Following centrifugation, supernatants were removed,
without disturbing the mononuclear layer at the interface, to
eliminate platelets. After a further centrifugation at 800 × g
for 20min, PBMC were collected from the interface. After
three washes with RPMI, PBMC were resuspended in complete
RPMI (RPMI 1640 added with 10% heat inactivated autologous
plasma and 2mM L-glutamine). Preformed biofilms (24 h-
old) of P. aeruginosa were gently washed three times with
PBS to remove non-adherent bacteria and 200 µl of PBMC
suspension (2 × 106 cells/ml) was added to P. aeruginosa
biofilms (i.e., 4 × 105 PBMC/well). PBMC:biofilm co-cultures
were incubated at 37◦C in 5% CO2 for 24 h. PBMC alone
were used as a negative control, while PBMC stimulated
with 5µg/ml phytohemagglutinin (PHA, Sigma-Aldrich, St
Louis, MO) were used as a positive control of cell reactivity.
Wells containing biofilms without PBMC were also established
for bacterial count. Following incubation, PBMC suspensions,
collected from six wells of each experimental condition were
pooled. A 50 µl aliquot was taken from each sample for cell
viability assessment prior to centrifugation at 500 × g for
5min. Supernatants were collected from each condition, sterile
filtered (0.22µm), aliquoted, and stored at −80◦C for further
assays (i.e., cytokine determination and biofilm stimulation). The
PBMC pellet was resuspended in PBS and cell surface staining
was performed.
Evaluation of Cell Viability by Trypan Blue
Dye Exclusion Test
Viability of PBMC was assessed after 24 h co-culture with P.
aeruginosa biofilms by the trypan blue dye exclusion test. To
this aim, PBMC incubated alone, co-cultured with preformed
biofilms, or stimulated with PHA were diluted 5 fold with 0.4%
trypan blue, added into a Burker counting chamber (Sigma-
Aldrich), and observed under 400× magnification with light
microscope (Olympus CH20BIMF200, Olympus optical Ltd,
Japan). Alive (clear) and dead (blue) cell numbers were assessed
independently by two operators and the counts obtained from six
fields were averaged.
Immunofluorescence Staining for Cell
Surface Markers
PBMC incubated with and without biofilm or stimulated with
PHA were subjected to surface staining for activation and
cell surface markers. Two- or three-color immunofluorescence
staining was performed as previously described (Esin et al., 2013).
Briefly, the cells were washed with PBS by centrifugation at 500
× g for 5min at 4◦C and incubated with saturating amounts of
monoclonal antibodies (MAbs) directed against cell surface or
activation markers for 30min at 4◦C.
The following MAbs were used for the staining: fluorescein
isothiocyanate (FITC)-conjugated anti-CD3 or anti HLA-DR;
PE-conjugated anti-CD14, anti-CD19, or anti-CD69 (Miltenyi
Biotec, Bergisch Gladbach, Germany); rhodamine-PE-cyanin
5.1(PC5)-conjugated anti-CD56 MAb (Beckman Coulter srl,
Milan, Italy). Isotype matched mouse immunoglobulin G (IgG)
Mabs (Miltenyi Biotec) were used as negative controls.
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Following staining and a wash with PBS, the cells were
fixed with 1% paraformaldehyde in PBS (Sigma-Aldrich) for
24 h at 4◦C. After a wash with PBS, at least 50000 events
were acquired ungated in a BD Accuri C6 flow cytometer
(BD Biosciences, San Jose, CA, USA). BD Accuri C6 software
(BD Biosciences) was used for computer-assisted analyses.
For the analyses, cells of interest were selected by a widely
set gate on a two-parameter plot of side scatter (SSC)
vs. forward-angle scatter (FSC) excluding debris and events
not of interest; among these cells the percentage and/or
mean fluorescence intensity (MFI) of the surface markers
were calculated according to following panel combinations:
negative control-FITC/-PE/-PC5; CD3-FITC/CD69-PE/CD56-
PC5; HLA-DR-FITC/CD19-PE.
Determination of Cytokines in Culture
Supernatants
The levels of a panel of cytokines (IL-1β, IL-6, IL-10, IL-4, IL-
8, IFN-γ, TNF-α) present in the co-culture supernatants were
determinated by a flow cytometer based multibead capture assay
(LEGENDplexTMMulti-Analyte Flow Assay Kit, BioLegend Inc.,
San Diego, CA, USA) according to manufacturer’s instructions.
Sensitivities of the assay were as follows: IL-1β, 0.65 ± 0.47
pg/ml; IL-4, 0.97 ± 0.83 pg/ml; IL-6, 0.97 ± 1.46 pg/ml; IL-
8, 1.90 ± 0.65 pg/ml; IL-10, 0.77 ± 1.18 pg/ml; IFN-γ 0.76 ±
0.53, pg/ml; TNF-α, 0.88 ± 0.27 pg/ml. Samples were acquired
in a BD Accuri C6 flow cytometer (BD Biosciences), analyzed
with LegendPlex v8.0 Software (BioLegend Inc.), and referred
to a standard curve. Results were expressed as pg/ml or ng/ml
depending on the cytokine.
Incubation of P. aeruginosa Biofilms With
Supernatants From PBMC-Biofilm
Co-culture
Preformed 24 h-old P. aeruginosa ATCC 27853 biofilms were
washed three times with PBS. Supernatants, obtained from
wells of PBMC co-cultured with P. aeruginosa biofilms (see
“PBMC:biofilm co-culture” above), were diluted 1:1 with fresh
complete RPMI and added to the biofilms. Following a 24 h
incubation at 37◦C, the number of biofilm-associated cells
was evaluated by CFU count, as described before. In some
experiments, the effect of PBMC-biofilm supernatants derived
from two different donors were assessed against 24 h-old biofilms
of P. aeruginosa PAO1 strain and two P. aeruginosa clinical
isolates (PA-AF and PA-CF).
Statistical Analysis
The statistical significance of the data was determined by
Student’s t-test for paired samples or by non-parametric
Wilcoxon signed-rank test. For multiple comparisons ANOVA
for matched samples followed by Tukey-Kramer multiple
comparisons test were used. A P-value of < 0.05 was
considered significant.
RESULTS
Formation of P. aeruginosa Biofilms in
Complete RPMI 1640 Medium at 24 and
48 h
The biofilm forming ability of P. aeruginosa ATCC 27853
in an eukaryotic cell-compatible medium was assessed by
incubating stationary phase P. aeruginosa in complete RPMI
1640 medium. Following 24 and 48 h of incubation at 37◦C
biofilm, viability and structure were evaluated by CLSM analysis.
As shown in Figure 1, at both 24 and 48 h, typical micro-
colonies attached on the slide were observed. Moreover,
Syto9/PI staining demonstrated that most of the bacterial
cells within the biofilm structure were alive, confirming the
ability of P. aeruginosa to successfully form biofilm in the
adopted conditions.
Evaluation of PBMC Viability Upon
Incubation With Preformed P. aeruginosa
Biofilms
The viability of PBMC upon incubation with preformed P.
aeruginosa biofilms in complete RPMI medium was assessed by
trypan blue dye exclusion test. Preliminary experiments were
performed to establish an incubation time long enough to
measure immune functions of PBMC with minimal cell death
(data not shown). As depicted in Figure 2, PBMC incubated for
24 h with P. aeruginosa biofilms were 90 ± 3% alive and this
was comparable to cells stimulated with a mitogen (PHA, 87
± 9%). The viability of PBMC incubated alone was 95 ± 4%,
indicating that the conditions adopted for in vitro PBMC:biofilm
co-cultures allowed to keep the human cells alive at acceptable
levels for 24 h.
Activation of PBMC Subsets Upon 24h
Co-culture With P. aeruginosa Biofilms
After gradient separation and before adding on biofilms, the
PBMC typically consisted of 72.8 ± 2.9% CD3+ T cells, 8.5 ±
0.8% CD3−CD56+ NK cells, 9.7 ± 4.4% CD14+ monocytes and
9.0 ± 2.0% CD19+ B cells. To evaluate whether PBMC:biofilm
co-culture induced activation of PBMC, cells were harvested
at 24 h and stained with MAbs directed against cell surface
subset markers (CD3+, T cells; CD56+CD3−, NK cells; CD19+,
B lymphocytes; CD14+, monocytes) and the early activation
marker CD69 (for T and NK cells) or for HLA-DR (for
B lymphocytes).
As an average of seven different donors, T and NK cells co-
cultured for 24 h with P. aeruginosa mature biofilms expressed
the early activation marker CD69 at statistically higher levels as
compared to PBMC incubated alone (CD69+ CD3+ T cells, 11.5
± 1.6% vs. 1.6 ± 0.3% P < 0.001, Student’s t-test for paired
samples; CD69+ CD3− CD56+ NK cells, 6.4 ± 2.3% vs. 0.6
± 0.2% P < 0.05, respectively; see Figure 3 for data from a
representative donor). As professional antigen presenting cells,
B lymphocytes constitutively express HLA-DR marker whose
intensity increases upon antigen-driven activation (Liu et al.,
2017). Although the percent of B lymphocytes incubated with
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FIGURE 1 | CLSM images of P. aeruginosa ATCC 27853 biofilm formed in RPMI medium. The viability of P. aeruginosa and the biofilm structure were evaluated upon
(A) 24 and (B) 48 h of culture in complete RPMI 1640 at 37◦C. After a wash to eliminate planktonic bacteria, P. aeruginosa biofilms were stained with green fluorescent
labeled Syto 9 (488/500–540 nm) for alive bacteria and with red fluorescent propidium iodide (PI, 488/600–650 nm) for dead bacteria. Figure shows results from a
representative experiment of the two performed. Dashed square indicates the 3x zoomed area. Scale bar = 25µm.
FIGURE 2 | Viability of PBMC incubated with preformed P. aeruginosa biofilms
for 24 h. PBMC were collected after 24 h of incubation in the absence (PBMC
only) and in the presence (Biofilm + PBMC) of preformed biofilms, or
stimulation with a mitogen (PHA + PBMC) in complete RPMI, and percentage
of live and dead cells were assessed by trypan blue exclusion test. Mean
values ± SEM from six independent experiments are shown.
P. aeruginosa biofilms was significantly higher than that of
PBMC incubated alone, no significant increase in the HLA-DR
mean fluorescence intensity was observed on CD19+ cells upon
co-culture with P. aeruginosa biofilms or incubation with PHA
(Supplementary Figure 1).
Next, we analyzed the percentage of activated cells within
each cell subset (Figure 4). Interestingly, upon 24 h of co-
culture with preformed P. aeruginosa biofilms, 17 ± 3% of
all T cells were activated whereas the percentage reached
the value of 60 ± 8% in the case of CD56+CD3− NK
cells (P < 0.05). In some donors, as much as 85.7% of
CD56+CD3− NK cells were activated (Figure 3I). Therefore,
the NK cell subset represented the most activated cell subset
upon stimulation with P. aeruginosa biofilms. Only 3 ± 1%
of T cells and 9 ± 4% of NK cells, were activated when
the PBMC were incubated alone (Figure 4). As expected, the
stimulation of PBMC with PHA resulted in an increase of
activated cells that were mainly expressing the T cell marker
CD3+ (Figures 3M, 4). In this case, 29 ± 8% of T cells were
activated, while the mean percentage of the NK cells was 17 ±
7% (Figure 4).
In all experimental conditions, CD14+ cells among harvested
PBMC were <0.5%, suggesting that monocytes adhered or
remained entrapped within the biofilm during the incubation or
were lysed in the attempt to ingest biofilm cells.
Cytokine Secretion Profile of PBMC
Co-cultured With P. aeruginosa Biofilms
In order to establish whether cell activation resulted in functional
activity of PBMC co-cultured with P. aeruginosa biofilms,
we evaluated the cytokine profile (IL-1β, IL-4, IL-6, IL-8,
IL-10, TNF-α, IFN-γ) in the co-culture supernatants and
compared it to that of PBMC incubated alone or stimulated
with PHA.
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FIGURE 3 | Activation of PBMC subsets upon 24 h of incubation with preformed P. aeruginosa biofilms. Dot plots from a representative experiment are shown. PBMC
incubated alone (A–E), co-cultured for 24 h with preformed P. aeruginosa biofilms (F–J), and incubated with a mitogen [PHA, (K–O)] were harvested and surface
stained with MAbs against cell subset markers (CD3+ T cells, CD56+CD3− NK cells, CD19+ B cells), activation marker CD69 (for T and NK cells), and HLA-DR.
(A,F,K) A gate (red dotted lines) which includes resting and activated live PBMC was set for the analyses. (B,G,L) Isotype matched mouse IgGs, used as negative
controls (isotype control for PC5 is not shown). (C,H,M) T cells, (D,I,N) NK cells (CD69 staining on CD56+CD3− cells gated from CD3 vs. CD56 plots are shown),
(E,J,O) B cells.
Among the pro-inflammatory cytokines tested, IL-1β, IFN-γ,
IL-6, and TNF-α were significantly increased in the supernatants
of PBMC co-cultured 24 h with P. aeruginosa biofilms in
comparison to PBMC incubated in the absence of bacteria,
whereas there were no significant differences in the IL-8
levels (Figure 5). Interestingly, in addition to pro-inflammatory
cytokines, anti-inflammatory cytokine IL-10 was also produced
at relatively high levels by PBMC co-cultured in the presence of
P. aeruginosa biofilms as compared to PBMC incubated alone.
The amount of IL-4 secreted into culture supernatants was very
low overall and without any significant differences. As expected,
PHA stimulated the secretion ofmost of the tested cytokines from
PBMC (Figure 5).
Effect of PBMC: Biofilm Co-culture on the
CFU Number of Biofilm-Associated
P. aeruginosa
In order to investigate whether PBMC could affect the
number of biofilm-associated P. aeruginosa upon 24 h of
co-culture, preformed P. aeruginosa biofilms (24 h old)
were incubated in the presence or absence of PBMC from
different donors for further 24 h. After gently washing biofilm
3 times with warm PBS to remove planktonic bacteria and
PBMC without disrupting the biofilm, biofilm-associated
bacteria were harvested by mechanically disrupting the
biofilm and plated on TSA. Interestingly, as shown in
Figure 6, a statistically higher CFU number was obtained
from biofilm incubated in presence of PBMC from different
donors as compared to the corresponding biofilms cultured
without PBMC (P < 0.01), indicating that co-cultivation of
P. aeruginosa biofilms with PBMC enhances the number of
biofilm-associated bacteria.
Effect of Supernatants From PBMC:Biofilm
Co-culture on P. aeruginosa Biofilms
To test the hypothesis that soluble factors produced during
PBMC:biofilm co-culture could stimulate the growth of P.
aeruginosa biofilms, we collected culture supernatants upon 24 h
co-culture of PBMC with preformed P. aeruginosa biofilms.
The supernatans, diluted 1:1 with fresh complete RPMI, were
added to 24 h-old biofilms of P. aeruginosa. The number
of biofilm-associated bacteria was evaluated after further 24 h
incubation and compared with that of biofilms incubated without
supernatants. As shown in Figure 7A, the CFU count of biofilm-
associated P. aeruginosa, incubated in the presence of the
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FIGURE 4 | Activated cells among T and NK cell subsets. Percentages of
activated (CD69+) cells within T cell- (blue symbols) and NK cell (red symbols)
-subsets, respectively, were calculated following 24 h incubation of PBMC
alone, with preformed P. aeruginosa biofilms, or with a mitogen (PHA).
**P < 0.01, Student’s t-test for paired samples, n = 7. Black lines indicate
mean values. Each symbol indicates a different donor/experiment.
supernatants, resulted two to seven times higher than that of
biofilms incubated alone (P < 0.01).
In some experiments, we incubated 24 h old P. aeruginosa
biofilms in the presence of supernatants obtained from PBMC
stimulated with PHA, PBMC incubated alone, or from 24 h old
P. aeruginosa biofilms incubated for an additional 24 h in the
absence of PBMC. In all such experiments, no enhancement
in the CFU of biofilm associated bacteria was observed
(Supplementary Figure 2).
Next, we investigated whether the observed effect on P.
aeruginosa ATCC 27853 biofilm growth was a strain specific
phenomenon, or could also be true for other P. aeruginosa
strains. To this aim, two different supernatants previously
demonstrated to have high biofilm-enhancing ability toward the
P. aeruginosa ATCC 27853 strain were selected (Sup 1 and
Sup 2, Figure 7B). The two supernatants were added to 24 h old
P. aeruginosa biofilms of PAO1 strain and two clinical isolates
(PA-AF and PA-CF) and incubated for further 24 h. Although
with some differences, both supernatants significantly enhanced
biofilm growth of all the three strains tested as compared to
the corresponding biofilms incubated in the absence of the
supernatants (Figure 7B).
DISCUSSION
P. aeruginosa is a ubiquitous environmental bacterium that can
be isolated from different habitats, including water, soil, and
plants. The bacterium is also an important opportunistic human
pathogen causing serious infections in immunocompromised or
hospitalized patients. The large majority of infections caused
by P. aeruginosa rely on the ability of the bacterium to form
biofilm. The host response, both the innate and the acquired
arms, may play a relevant role in the course of biofilm infections
(Moser et al., 2017). Although a detailed knowledge of the host
immune response to biofilms is still lacking, it appears that the
host is mostly unable to eliminate the pathogen in the form of a
biofilm. In such form, the pathogen rather persists establishing
a chronic infection where the immune response, instead of
being protective, may even accelerate collateral tissue damage
(Moser et al., 2017). Chronic P. aeruginosa infections may persist
for months to decades, as in the case of pulmonary infection
in individuals with CF, during which a complex and dynamic
interplay between the pathogen and the host establishes.
In the present study, in order to get further insights on the
intricate relationship between P. aeruginosa and host immune
cells, we have established an in vitro co-culture model of
P. aeruginosa biofilms and PBMC from healthy blood donors.
P. aeruginosa biofilms have been previously obtained in vitro
using different types of bacteriological or synthetic media
supplemented with various nutrients or growth factors (Haney
et al., 2018; Wijesinghe et al., 2019). It is generally agreed that the
nutrient contents of the culture medium may greatly impact the
biofilm growth and development of different microbial species
(Stepanovic´ et al., 2007; Seneviratne et al., 2013; Weerasekera
et al., 2016). In order to create an environment simulating the
in vivo condition and suitable to assess immune cell responses,
herein we obtained mature P. aeruginosa biofilms in RPMI
1640 supplemented with human plasma, a medium that is
normally used for the growth of eukaryotic cells, but not for
bacteria. Such medium resembles the composition of body
fluids of the human host, as it contains high concentrations
of amino acids, such as L-glutamine, L-arginine, L-asparagine,
as well as vitamins and inorganic salts (Kucharíková et al.,
2011). Confocal microscopy analyses, performed following 24
and 48 h of incubation of stationary phase P. aeruginosa in such
medium, clearly demonstrated the presence of adherent bacterial
cells organized to form characteristic microcolonies separated
by empty spaces, resembling the water channels that are
characteristic of P. aeruginosa biofilm structure (Rasamiravaka
et al., 2015). Vital staining showed that most of bacterial cells
were alive, confirming the ability of the RPMI 1640 medium to
sustain the development of P. aeruginosa biofilms. A co-culture
time of 24 h of PBMC with preformed P. aeruginosa biofilms
was sufficient to induce cell activation with limited cell death.
As an average of different donors approximately 12% of the
PBMC, harvested following P. aeruginosa biofilm co-incubation,
were activated T lymphocytes (CD3+CD69+ cells). Such an
activation might result from a non-specific direct stimulation
or from cytokines released by monocytes, but it might also be
compatible with a secondary response to P. aeruginosa antigens,
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FIGURE 5 | Cytokine profiles of PBMC stimulated with P. aeruginosa biofilm. The supernatants were collected after 24 h from wells in which PBMC incubated alone
(red bars), with preformed P. aeruginosa biofilm (black bars), or stimulated with a mitogen (PHA, blue bars) in complete RPMI. Cytokine amount was evaluated by flow
cytometer based multibead capture assay. Mean values ± SEM from 10 independent experiments are shown *P < 0.05, **P < 0.01, ***P < 0.001, ANOVA for
matched samples and Tukey-Kramer multiple comparisons test.
as the blood donors might have been sensitized by environmental
exposure to P. aeruginosa, a bacterium widely distributed in
the environment. Still little is known about the existence of
biofilm-specific antigens and whether they are “seen” by host
immune cells. Obvious candidates are components of the EPS,
a highly hydrated mixture of extracellular DNA (bacteria- and
host-derived), proteins, polysaccharides, and lipids whose effects
on host cells appear to be of great complexity ranging from
immunogenic to anti-immunogenic according to the microbial
species or strains considered (Watters et al., 2016). Only few
studies have investigated the T cell response to bacterial biofilms
and most of them have been focused on Staphylococcus biofilms
with some conflicting results (Prabhakara et al., 2011; Hanke
et al., 2013). Early work carried out in different mouse strains
intratracheally infected with P. aeruginosa, has demonstrated that
the Th1-reacting C3H/HeN mice show a better disease outcome
compared to the Th2-reacting BALB/c mice, suggesting that
a Th1 response might be beneficial in chronic P. aeruginosa
pulmonary infection (Moser et al., 1999). It is possible that
different T cell subsets (Th1, Th2, Th17, Treg) take part to the
response and that, similarly to other chronic infections, a balance
between antigen-specific pro-inflammatory (Th1/Th17) and
anti-inflammatory (Th2, Treg) T cells is required for ensuring a
protective effect and a limited tissue damage (Ehlers, 1999).
A very interesting result that emerged from our study is the
striking activation of CD56+CD3− cells (NK cells) following
24 h PBMC exposure to P. aeruginosa biofilm. As an average,
60% of NK cells expressed the early activation marker CD69
upon stimulation with P. aeruginosa biofilms and the percentage
reached very high levels in some donors (up to 86%). NK
cells are traditionally considered as “nonspecific” or “innate”
effector cells, meaning that they do not recognize bacteria
in an antigen-specific manner and do not generate memory
responses. Such view has been challenged over the last years
when it became clear that NK cells might be endowed with
those properties that for a long time have been ascribed only
to cells of specific immunity (e.g., immunological memory)
(Narni-Mancinelli et al., 2011; Sun et al., 2011), placing such
cells at the interface between innate and adaptive immunity.
The main route to the activation and functional activity of NK
cells is via soluble factors (e.g., IL-12; IL-1β; TNF-α) released
by accessory cells (monocytes; macrophages; dendritic cells) or
T cells (e.g., IL-2). Nevertheless, we and others have provided
strong evidence that NK cells express functional “pathogen
recognition receptors” (PRRs) that can directly interact with
“pathogen associated molecular patterns” (PAMPs), resulting in
cell activation and functional activity (Chalifour et al., 2004;
Esin et al., 2008, 2013). Thus, NK cell activation observed
in the present study might be due to soluble factors present
in the supernatants of PBMC:biofilm co-cultures, as well as
to a direct recognition of yet unidentified biofilm-associated
PAMPs by such cells. Putative NK cell receptors involved in
the direct recognition of microbial ligands are numerous and
include several members of the TLR family (e.g., TLR2, TLR4,
TLR5, TLR9), intracellular receptors such as NOD2, or members
of the natural cytotoxicity receptor (NCR) family (Esin and
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FIGURE 6 | The effect of PBMC:P. aeruginosa biofilm co-culture on the
number of P. aeruginosa biofilm associated bacteria. Preformed (24 h old)
P. aeruginosa biofilms were cultured in the presence or absence of PBMC
obtained from different donors for further 24 h, and the numbers (CFU) of
biofilm associated bacteria were assessed. Each donor/experiment is
represented by a different color. Black lines represent median
values.**P < 0.01, Wilcoxon signed-rank test, n = 10.
Batoni, 2015). In this regard, we have previously reported that,
unlike a number of Gram-negative bacteria, a soluble form
of the NCR family member NKp44 is able to bind intact
P. aeruginosa cells suggesting the existence of putative ligands
for this receptor on the bacterium surface (Esin et al., 2008).
Interestingly, it has been demonstrated that a fraction of human
NK cells express basal levels of TLR9 and respond to bacterial
DNA containing a high frequency of unmethylated CpG motifs
(Ashkar and Rosenthal, 2002; Roda et al., 2005). Since bacterial
DNA is an essential component of the EPS of P. aeruginosa
biofilms, it might be possible that such componentmay represent,
among others, a biofilm-specific ligand able to activate immune
NK cell response (Watters et al., 2016). Another receptor
expressed on NK cells (and on other immune cells) thought
to be involved in host defense against P. aeruginosa infection
is NKG2D (Wesselkamper et al., 2008). NKG2D ligands are
markedly induced by P. aeruginosa on pulmonary epithelial cells
and the receptor seems critical for mouse protection following
respiratory infection with the bacterium. Importantly, host-cell
expression of NKG2D ligands was demonstrated to increase
cytokine production by NK cells in response to a bacterial
TLR-ligand such as LPS, suggesting a possible synergistic effect
between different NK cell receptors in the response of NK cells to
P. aeruginosa (Wesselkamper et al., 2008).
Once activated, NK cells express a variety of effector
functions including cytotoxicity, production of high amounts of
immunoregulatory cytokines (e.g., IFN-γ; TNF-α), production
of antibacterial mediators (e.g., NO, α-defensins, granulysin),
regulation of other cell type-functions and, in certain
circumstances, direct bactericidal activity (Esin and Batoni,
2015) disclosing putative roles of such cells in immunity against
biofilms. Of note, consistently with the large proportion of NK
cell activation observed in the present study, high amount of IFN-
γ were found in the supernatant of PBMC:biofilm co-culture.
Interestingly, IFN-γ production by human NK cells stimulated
with P. aeruginosa has been previously reported by Vourc’h and
coworkers who demonstrated that such production is enhanced
by NK priming with IL-12, but is STAT-4 pathway-independent
(Vourc’h et al., 2017). The same group also demonstrated that
direct bacteria-to-cell contact is necessary for IFN-γ production
and the type 3-secreted exoenzyme T (Exo T) of P. aeruginosa is
the main trigger of IFN-γ release (Vourc’h et al., 2017). Another
study reported that IFN-γ release from PBMC correlates with an
improved lung function in CF patients chronically infected by P.
aeruginosa, suggesting a possible protective role of IFN-γ in vivo
and a putative beneficial effect of IFN-γ treatment (Moser et al.,
2000). To the best of our knowledge, massive activation of NK
cells upon stimulation with P. aeruginosa biofilms is a finding
previously not reported and point out possible roles for these
cells in the response to bacterial biofilms.
Analysis of the cytokine pattern in the supernatants of
PBMC:biofilm co-cultures also revealed relatively high levels
of the anti-inflammatory cytokine IL-10. Such observation is
consistent with the view that bacterial biofilms are able to skew
the immune response toward an anti-inflammatory phenotype
that promote bacterial persistence at late stage of an infection
(González et al., 2018; Campoccia et al., 2019).
Interestingly, the present study demonstrated that not only
P. aeruginosa biofilms induced activation and response of
PBMC, but also the presence of PBMC or supernatant derived
from PBMC:biofilm co-cultures caused a statistically significant
increase of biofilm-associated P. aeruginosa. Such enhancement
was observed using PBMC from different donors as well as
employing different P. aeruginosa clinical strains suggesting
that the stimulatory capacity of PBMC on P. aeruginosa
biofilms might have important implications in the pathogenesis
of P. aeruginosa-associated colonization of medical devices
such as intravenous catheters. The increase in the number of
biofilm cells in the presence of supernatants from PBMC:biofilm
co-cultures suggests that soluble factors, released in the
extracellular environment upon interaction of eukaryotic cells
with P. aeruginosa biofilms, might be responsible for the
observed stimulatory effect. Such effect did not seem to be
due to bacterial factors (e.g., inducers of quorum sensing), in
fact, biofilm supernatants obtained in the absence of PBMC
did not exerted the same biofilm-enhancing effect. Neither
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FIGURE 7 | The effect of supernatants, obtained from co-culture of PBMC with 24 h old P. aeruginosa biofilms, on P. aeruginosa biofilm associated bacteria number.
(A) Preformed P. aeruginosa ATCC 27853 biofilms (24 h old) were incubated for further 24 h in the presence or absence of supernatants obtained from PBMC
co-cultured with preformed P. aeruginosa biofilm for 24 h (n = 10) and the numbers (CFU) of biofilm associated bacteria were assessed. Black lines represent median
values. (B) Preformed biofilms of clinical P. aeruginosa strains (PAO1, PA-AF, and PA-CF) were incubated for an additional 24 h with supernatants obtained from two
different donors’ PBMC co-cultured with P. aeruginosa ATCC 27853 biofilms (n = 7); data are presented as the median and interquartile range. *P < 0.05, **P < 0.01,
Wilcoxon signed-rank test.
supernatants stimulated with the mitogen PHA were able
to enhance biofilm growth, suggesting that the stimulatory
capacity of the supernatants was biofilm-specific and not
due to a non-specific activation of host cells. It has been
proposed that P. aeruginosa biofilms “sense” the presence of
host immune components and actively react to promote its
own persistence (Wu et al., 2005; Hänsch, 2012). For instance,
Alhede and coworkers demonstrated that P. aeruginosa biofilms
recognize and respond aggressively to the presence of human
polymorphonuclear leukocytes (PMNs) by upregulating the
synthesis of rhamnolipids, amphiphilic molecules composed of
rhamnose and hydrophobic fatty acid moieties, that represent
major virulence factors of the bacterium (Jensen et al.,
2007; Alhede et al., 2009). There is also evidence that
P. aeruginosa increases the formation of biofilm in the
presence of PMNs (Walker et al., 2005). Possibly, cytokines
or other host factors released in the supernatant upon cell
activation/lysis are recognized by bacteria that implement a
defensive/persistence strategy against the immune response. This
hypothesis is supported by previous findings demonstrating
that cytokines such as TNF-α, IL-1 or IL-6 do promote
bacterial growth (Porat et al., 1991; Meduri et al., 1999;
Kanangat et al., 2001) and that bacteria possess receptor-like
molecules for immune mediators (Luo et al., 1993). IL-1β
was shown to bind to and induce growth enhancement of
Staphylococcus aureus biofilms (McLaughlin and Hoogewerf,
2006). Similarly, Mittal and coworkers demonstrated a significant
enhancement in growth and virulence factor production when
both planktonic and biofilm cells of P. aeruginosa were grown
in the presence of supernatants containing mouse-peritoneal-
macrophage secretory products (MSPs) (e.g., TNF-α, TNF-
β, IL-1α, IL-β, GM-CSF, MIP-2, IL-6, IL-12, and IL-18, as
well as, reactive nitrogen intermediates) (Mittal et al., 2006).
Enhancement of biofilm formation by soluble factors released by
adherent PBMC was also described for the fungal opportunistic
pathogen Candida albicans (Chandra et al., 2007) suggesting that
biofilm responsiveness to cytokine production may represent
an adaptive response of different types of microbial pathogens
to counteract the host attack. Interestingly, Wu and coworkers
analyzed the ability of supernatants from antigen-stimulated T
cells to induce the expression of the type I P. aeruginosa lectin
(PA-I or lecA), an adhesin of P. aeruginosa taken by the authors as
representative quorum sensing-dependent virulence determinant
of this organism (Wu et al., 2005). They demonstrated that
PA-I expression was increased by supernatants from activated
T cell cultures and this effect was essentially ascribable to the
presence of IFN-γ in the supernatants. Of note, IFN-γ-mediated
increment in both transcription and translation of PA-I started
at early stationary phase of growth when bacteria are considered
structurally and metabolically assimilable to biofilm cells. Finally,
the authors demonstrated that IFN-γ directly binds to an outer
membrane protein of P. aeruginosa (OprF) resulting in the
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activation of quorum sensing, which is known to control the
expression of different virulence factors including the ability to
form biofilm (Wu et al., 2005). In the present study, when PBMC
were co-cultured with P. aeruginosa biofilms, high amounts of
IFN-γ were found in the culture supernatants, together with
elevated proportion of activated NK cells that are known to
be producers of IFN-γ. It is tempting to speculate that IFN-γ
released by activated NK cells (and/or T cells) upon incubation
with P. aeruginosa biofilms may represent a double-edged sword
that is capable of expressing beneficial effector functions against
biofilms, but at the same time potentially able to trigger evasion
mechanisms of P. aeruginosa through activation of quorum
sensing system and enhancement of biofilm formation (Moser
et al., 2017).
Overall, the findings from the present study suggest that
host PBMC are able to activate and produce cytokines upon
interaction with P. aeruginosa biofilm. On the other hand,
biofilm cells acquire the ability to grow more rapidly when
challenged with mediators released from activated immune
cells revealing a mechanism that may contribute to the ability
of biofilms to resist clearance by host defenses and establish
chronic infections. Much research effort is still needed to fully
clarify the complex mechanisms and pathways that regulate
the mutual interactions between the host immune system and
P. aeruginosa biofilms. Previously unrecognized elements (e.g.,
NK cells) may participate to the host immune response to
P. aeruginosa biofilms, adding complexity to the host:biofilm
interaction but also paving the way for the identification
of new immunotherapeutic strategies for the control of
biofilm infections.
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